Abbvie (ABBV) prelim Q2 26 adj. EPS: 3.57-3.61 (exp. 3.79); Cuts FY 26 adj. EPS view 13.91-14.11 (exp. 14.28, prev. 14.08-14.28); reflects impact of acquired IPR&D and milestone expenses